K2 Principal Fund’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

K2 Principal Fund’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,505	Closed	-$405K	–	310
2023 Q2	$405K	Buy	+39,505	New	+$403K	0.09%	126

K2 Principal Fund's DALS Position: Q3 2023 in Review

K2 Principal Fund sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 39,505 shares — an estimated $405K sold.

K2 Principal Fund first reported a position in DALS in Q2 2023 and held it in 1 quarter. The position peaked at $405K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

K2 Principal Fund reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
K2 Principal Fund sold 39,505 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $405K.
K2 Principal Fund first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q2 2023 and held it in 1 quarter.
K2 Principal Fund's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $405K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on K2 Principal Fund's 13F filing for Q3 2023, filed 13 Nov 2023.